Free shipment in The Netherlands & Belgium

About Chrono Eyewear and PROPEAQ

The company behind the PROPEAQ brand is Chrono Eyewear, a Dutch company founded in 2015 by Toine Schoutens.

The name Chrono refers to the biological clock, also known as the circadian rhythm or sleep–wake cycle, the natural mechanism that determines when we are active and when we rest. Eyewear refers to the form of our products: wearable light therapy in the shape of glasses.

Our mission is to improve people’s quality of life worldwide through wearable light therapy. We achieve this by:

  • Developing and producing innovative light therapy solutions that allow you to actively manage your biorhythm.
  • Creating greater awareness of the power of light and its influence on health, energy, and wellbeing.

    At Chrono Eyewear, we believe that light is the key to balance, energy, and recovery.

    Read below to learn more about the history of Chrono Eyewear and PROPEAQ, and discover how we work every day towards the future of smart light.

PROPEAQ History

1987

First introduction to light therapy

PROPEAQ founder Toine Schoutens first encountered light therapy during his work as a nurse, when he was asked to research its effects on seasonal depression. He was immediately fascinated by the powerful influence of light on mood and energy. Based on the study’s results, Toine developed a treatment protocol and built the first prototype light box. His findings were later presented at the conference of the Dutch Association for Psychiatry.

1994

Collaboration with Philips

Toine worked for Philips, where he was involved in the development of the Philips Original Bright Light and the Philips Wake-Up Light. During this time, he further expanded his technological expertise in light and health.

1999

Research at TU/e

Toine was approached by Professor Dr Ton Begemann to collaborate within the Light and Health Research Foundation, affiliated with the Eindhoven University of Technology. This partnership provided the opportunity to conduct long-term, in-depth research into the effects of light on health and performance.

2007

First prototypes

Toine developed the first prototypes of the wearable light therapy glasses, making light therapy mobile and personal for the very first time. It was a major step towards making light therapy accessible beyond the clinical environment.

2008

Breakthrough at the Olympic Games

The wearable light therapy glasses were used for the first time during the Beijing Olympic Games. Maarten van der Weijden incorporated the glasses into his preparation and went on to win gold in the 10 km open water swimming event. It was an iconic moment that confirmed the potential of light therapy in achieving peak athletic performance.

2015

The founding of PROPEAQ

Founding of Chrono Eyewear and the PROPEAQ brand. The name PROPEAQ combines the words “professional” and “peak performance”, symbolising the pursuit of optimal performance through smart use of light.

2016

Introduction of first PROPEAQ light glasses

The first PROPEAQ light therapy glasses were launched and immediately adopted by several Olympic sports teams during the Rio de Janeiro Summer Games. Among the early users were the Australian Dolphins, Dutch gymnasts, athletes, and swimmers, as well as the Belgian national swimming team. In addition to elite sports, the glasses soon found wider applications, including use by people working irregular or night shifts.

2017

Research into Parkinson’s disease

The first scientific study on the effects of the PROPEAQ light therapy glasses in people with Parkinson’s disease was launched. The results showed improved sleep, reduced daytime sleepiness, and a more positive mood among participants. The findings were published in 2019.

View the publication

2018

Olympic games PyeongChang

During the PyeongChang Winter Olympic Games, several teams used the PROPEAQ light therapy glasses, including the Dutch speed skaters and short track teams, Swiss skiers, Belgian bobsleigh athletes, and the Danish curling team. Since 2012, multiple international Olympic teams have relied on PROPEAQ at every edition of the Games to optimise their performance and maintain a balanced circadian rhythm across time zones.

2020

Additional research into Parkinson's

Following the successful results of 2017, a large-scale randomised controlled trial (RCT) was launched in 2020 to study the effects of the PROPEAQ light therapy glasses in people with Parkinson’s disease. Due to the COVID-19 pandemic, the study has experienced significant delays. The publication of the results is expected in autumn 2025.

2025

Growth and innovation

The PROPEAQ team expanded and launched a new website and webshop.
As activities scaled up, the development of the innovative Smart Safety Glasses marked a new phase in light technology. Together with its partners GBO Innovation Makers and Dual Inventive, PROPEAQ received an iF Design Award in recognition of the groundbreaking design of the Smart Safety Glasses.

Meet the team

We're pleased to introduce ourselves

Toine Schoutens

Marc Schoutens

Kees Huussen

Esther Groenhuijzen

Jelle van Abeelen

Wouter Quispel